|
| [January 08, 2013] |
 |
Law Office of Brodsky & Smith, LLC Announces Investigation of Epocrates, Inc.
BALA CYNWYD, Pa. --(Business Wire)--
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Epocrates, Inc.
("Epocrates" or the "Company") (Nasdaq: EPOC) relating to the proposed
acquisition by AthenaHealth, Inc. ("AthenaHealth").
Under the terms of the transaction, Epocrates shareholders will receive
only $11.75 in cash for each share of Epocrates stock they own. The
investigation concerns possible breaches of fiduciary duty and other
violations of state law by the Board of Directors of Epocrates for not
acting in the Company's shareholders' best interests in connection with
the sale process to AthenaHealth. The trnsaction may undervalue the
Company and will result in a loss for many shareholders. For example
Epocrates stock traded at $25.80 as recently as March 15, 2011. In
addition, an analyst has set a price target for Epocrates stock at
$15.00 per share and the Epocrates app is used by approximately 338,000
U.S. physicians.
If you own shares of Epocrates stock and wish to discuss the legal
ramifications of the proposed transaction, or have any questions, you
may e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your questions. You
may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at
Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004,
by e-mail at investorrelations@brodsky-smith.com
visiting http://brodsky-smith.com/526-epoc-epocrates-inc.html,
by calling toll free 877-LEGAL-90.
[ Back To HTML5's Homepage ]
|